AU1242495A - Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorous cholinesterase inhibitors - Google Patents

Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorous cholinesterase inhibitors

Info

Publication number
AU1242495A
AU1242495A AU12424/95A AU1242495A AU1242495A AU 1242495 A AU1242495 A AU 1242495A AU 12424/95 A AU12424/95 A AU 12424/95A AU 1242495 A AU1242495 A AU 1242495A AU 1242495 A AU1242495 A AU 1242495A
Authority
AU
Australia
Prior art keywords
prophylaxis
pharmaceutical formulation
cholinesterase inhibitors
pretreatment
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU12424/95A
Other versions
AU704020B2 (en
Inventor
Bodo Asmussen
Thomas Hille
Aharon Levy
Yacov Meshulam
Walter Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6504683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU1242495(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Publication of AU1242495A publication Critical patent/AU1242495A/en
Application granted granted Critical
Publication of AU704020B2 publication Critical patent/AU704020B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

PCT No. PCT/EP94/04049 Sec. 371 Date Aug. 23, 1996 Sec. 102(e) Date Aug. 23, 1996 PCT Filed Dec. 6, 1994 PCT Pub. No. WO95/15756 PCT Pub. Date Jun. 15, 1995A pharmaceutical formulation for the prophylaxis and preliminary treatment of a poisoning caused by organophosphorus cholinesterase inhibitors is characterized in that it consists of an active substance combination of at least one parasympathomimetic and at least one parasympatholytic.
AU12424/95A 1993-12-10 1994-12-06 Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorous cholinesterase inhibitors Ceased AU704020B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP4342173 1993-12-10
DE4342173A DE4342173A1 (en) 1993-12-10 1993-12-10 Pharmaceutical formulation for the prophylaxis or pretreatment of poisoning by organophosphorus cholinesterase inhibitors
PCT/EP1994/004049 WO1995015756A1 (en) 1993-12-10 1994-12-06 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors

Publications (2)

Publication Number Publication Date
AU1242495A true AU1242495A (en) 1995-06-27
AU704020B2 AU704020B2 (en) 1999-04-15

Family

ID=6504683

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12424/95A Ceased AU704020B2 (en) 1993-12-10 1994-12-06 Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorous cholinesterase inhibitors

Country Status (22)

Country Link
US (1) US6114347A (en)
EP (1) EP0732926B1 (en)
JP (1) JP3709204B2 (en)
KR (1) KR100374086B1 (en)
AT (1) ATE232726T1 (en)
AU (1) AU704020B2 (en)
CA (1) CA2178605C (en)
CZ (1) CZ291870B6 (en)
DE (2) DE4342173A1 (en)
DK (1) DK0732926T3 (en)
ES (1) ES2193185T3 (en)
FI (1) FI962369A (en)
HU (1) HUT74427A (en)
IL (1) IL111917A (en)
MY (1) MY116828A (en)
NO (1) NO962406L (en)
NZ (1) NZ277258A (en)
PL (1) PL314915A1 (en)
PT (1) PT732926E (en)
SK (1) SK282536B6 (en)
WO (1) WO1995015756A1 (en)
ZA (1) ZA949843B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2170649B1 (en) * 2000-03-29 2003-06-16 Ferrer Int USE OF CDP-HILL IN THE TREATMENT OF ALCOHOLIC ABSTINENCE.
WO2002092003A2 (en) * 2001-05-11 2002-11-21 Bacaner Marvin B Novel therapeutical quaternary ammonium compositions
GB2405336A (en) * 2002-05-01 2005-03-02 Eisai Co Ltd Cholinesterase inhibitors to prevent injuries caused by chemicals
DE10301851A1 (en) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Use of dialkylaminoalkylphenyl carbamate derivatives to protect humans from poisoning by cholinesterase inhibitors, including pesticides and chemical warfare agents
US20050013869A1 (en) * 2003-07-18 2005-01-20 Chaw Cheng Shu Sustained release formulation for carbamates and a method therefor
EP1663203A1 (en) * 2003-09-19 2006-06-07 The Secretary of State for Defence Pharmaceutical compositions for the treatment of organophosphate poisoning
US9308164B2 (en) 2004-06-30 2016-04-12 Sovereign Pharmaceuticals, Llc Hyoscyamine dosage form
AU2005289808B2 (en) * 2004-09-24 2011-11-03 The Government Of The United States As Represented By The Secretary Of The Army, U.S. Army Medical Research Institute Of Chemical Defense Method of treating organophosphorous poisoning
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
CN111773389A (en) * 2020-06-02 2020-10-16 杨卫国 A method for treating cattle poisoning

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3760806A (en) * 1971-01-13 1973-09-25 Alza Corp Helical osmotic dispenser with non-planar membrane
US3764984A (en) * 1972-01-28 1973-10-09 Benz G Information coding system
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
ZA796519B (en) * 1978-12-01 1980-11-26 Pfizer Preparation of 2-ketogulonic acid
JPS60189744A (en) * 1984-03-09 1985-09-27 Tokyo Color:Kk Method for regenerating color photographic developing solution
JPS62133457A (en) * 1985-12-04 1987-06-16 Konishiroku Photo Ind Co Ltd Method for processing silver halide color photographic sensitive material and device for processing developing solution
JPH03194552A (en) * 1989-12-22 1991-08-26 Fuji Photo Film Co Ltd Method for processing silver halide color photographic sensitive material
US5278035A (en) * 1990-01-31 1994-01-11 Knapp Audenried W Non-toxic photographic developer composition for processing x-ray films in automatic film processors
US5098819A (en) * 1990-01-31 1992-03-24 Knapp Audenried W Non-toxic photographic developer composition
DE4115558A1 (en) * 1991-05-13 1992-11-19 Dresden Arzneimittel PROPHYLACTIC ANTIDOT AGAINST PHOSPHORORGANIC GIFTS

Also Published As

Publication number Publication date
NO962406D0 (en) 1996-06-07
KR100374086B1 (en) 2003-07-23
EP0732926A1 (en) 1996-09-25
ZA949843B (en) 1995-09-01
FI962369A0 (en) 1996-06-07
KR960706341A (en) 1996-12-09
IL111917A (en) 1998-08-16
JPH09506361A (en) 1997-06-24
WO1995015756A1 (en) 1995-06-15
DE59410246C5 (en) 2008-09-25
CA2178605C (en) 2006-02-14
CZ291870B6 (en) 2003-06-18
US6114347A (en) 2000-09-05
EP0732926B1 (en) 2003-02-19
ATE232726T1 (en) 2003-03-15
IL111917A0 (en) 1995-03-15
DK0732926T3 (en) 2003-06-10
CA2178605A1 (en) 1995-06-15
DE4342173A1 (en) 1995-06-14
DE59410246D1 (en) 2003-03-27
AU704020B2 (en) 1999-04-15
NO962406L (en) 1996-06-07
FI962369A (en) 1996-08-02
MY116828A (en) 2004-04-30
SK73896A3 (en) 1996-12-04
PT732926E (en) 2003-06-30
ES2193185T3 (en) 2003-11-01
NZ277258A (en) 1999-09-29
HU9601599D0 (en) 1996-08-28
SK282536B6 (en) 2002-10-08
JP3709204B2 (en) 2005-10-26
HUT74427A (en) 1996-12-30
PL314915A1 (en) 1996-09-30
CZ168396A3 (en) 1996-10-16

Similar Documents

Publication Publication Date Title
IL111942A0 (en) A transdermal therapeutic system containing a parasympathomimetic compound and a parasympatholytic compound
ES2128552T3 (en) COMBINATION OF AN INHIBITOR OF THE BIOSYNTHESIS OF CHOLESTEROL AND AN INHIBITOR OF THE ABSORPTION OF BETA-LACTAMA CHOLESTEROL.
AU7994594A (en) Plaster for the treatment of nail mycoses
GEP20033131B (en) Azabicycloalkanes as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Activity
AU5217493A (en) Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
FI954990A (en) Transdermal preparation containing the active substance
AU1242495A (en) Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorous cholinesterase inhibitors
AU4923093A (en) Inhibitors of metazoan parasite proteases
ZA922297B (en) Crystalline tiababine monohydrate,its preparation and use
AU1812395A (en) Film coated tablet of paracetamol and domperidone
AU7784494A (en) Transdermal therapeutic system containing octyl dodecanol ascrystallization inhibitor
HU9601684D0 (en) Deuterised active agents in transdermal application
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
AU7941294A (en) Composition for the treatment or prevention of herpes
DE59510583D1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION WITH THE ACTIVE MORPHINE-6-GLUCURONIDE
AU665397B2 (en) Fungicidal compositions
MX9302986A (en) MEDICINES CONTAINING METRIFONATE AND PROCEDURE FOR ITS PREPARATION
WO1996001128A3 (en) Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets